Hemostasis Valves Market
Hemostasis Valves Market Forecast, Trend Analysis & Competition Tracking - Global Review 2021 to 2031
Analysis of Hemostasis Valves market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Hemostasis Valves Market Forecast and CAGR
According to the latest research by Fact.MR., the Hemostasis Valves Market is set to witness steady growth during 2021-2031. The increasing advancement in the hemostasis valves industry will offer lucrative opportunities and an increasing number of interventional procedures is propelling the market growth.
What is Driving the Demand for the Hemostasis Valves Market?
The growing preference for hemostasis valves by healthcare providers as they deliver efficiency in the next-generation catheter and delivery systems, the increasing number of interventional procedures in various medical specialities, and the rising number of coronary angiography procedures for the diagnosis of heart muscles is is expected to drive the market growth.
Coronary Angioplasty Is Likely To Accelerate The Hemostasis Valves Demand
Hemostasis valves are widely used in interventional procedures such as coronary angioplasty for reducing blood loss after interventional instrument insertion in human vasculature. A rising prevalence of heart diseases has resulted in a sharp increase in the number of endovascular surgeries, thus driving the market growth.
The US and Canada Hemostasis Valves Market Outlook
The US is one of the largest markets for hemostasis valves globally. The US Hemostasis valves market is set to tread on the historic pattern of bust and boom during the assessment period 2021-2031.
Demand for Hemostasis valves in the US and Canada will be led by the increasing number of interventional procedures in the country. The U.S. regulatory authorities are actively adopting several cost-containment plans to reduce their healthcare burden. A value-based healthcare system in the U.S. is likely to impact investments in the R&D programs of innovative hemostasis valves. Most of the leading players are launching a new product in the U.S., which will further create opportunities in the market. For instance, in May 2019, Merit Medical Systems Inc. have launched the Push, Hold and Deliver-PhD polycarbonate hemostasis valve, which allows surgeons and healthcare professionals to use the valve with one hand during interventional procedures.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Europe Demand Outlook for Hemostasis Valves Market
Many countries in the EU have been severely faced hardest hit by the COVID-19 crisis, which has led to a decline in economic activities. However, as is the case in the UK and Germany, healthcare spending in the EU continues to drive demand for hemostasis valves. Despite the COVID-19 challenges, most European countries have maintained a steady healthcare expenditure in 2020. For instance, The UK health care spending is budgeted at £177.7 billion. The strong estimates for Europe's healthcare expenditure would offer lucrative opportunities for the medical device manufacturers to expand their product portfolio of hemostasis valve. The use of hemostasis valve during coronary angiography procedures is increasing rapidly in Europe due to the increase in the geriatric population. Thus the market is expected to grow rapidly in the region.
Who are the Key Manufacturers and Suppliers of Hemostasis Valves?
Some of the leading manufacturers and suppliers of hemostasis valves include
- B. Braun Melsungen
- Boston Scientific
- Teleflex Incorporated
- DeRoyal Industries Inc.
- Excel Medical Products
- Argon Medical
- Freudenberg Medical
- Armstrong Medical
- Merit Medical
- St. Jude Medical
These key players are implementing innovative technologies to provide for the large unmet needs of the customers.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Hemostasis Valves Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company
By Product Type
- Conventional Hemostasis Valve
- Y-connector valve
- double valve
- one-handed valve
- straight connector valve
- side port tubing valve
- one-way valves
- Guardian Haemostasis Valve
- Neuroendovascular procedures
- Coronary interventional procedures
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Diagnostic Laboratories
- North America
- Latin America
- Rest of Latin America
- The U.K.
- Rest of Latin America
- East Asia
- South Korea
- South Asia
- Rest of South Asia
- New Zealand
- The Middle East and Africa
- GCC Countries
- North Africa
- South Africa
- Rest of the Middle East
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
- FAQs -
Hemostasis valves market is estimated to grow at a CAGR of 6.7% during the forecast period.
A growing number of interventional treatments and profitable prospects will be provided by the hemostasis valves industry's continued progress.
The U.S. is likely to be a region with lucrative opportunities for the hemostasis valves manufacturers.